Basics Harmony Biosciences Holdings, Inc. IPO Date: August 19, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.29B Activated in VL: True Average Daily Range Avg Daily Range: $0.78 | 2.10% Avg Daily Range (30 D): $0.62 | 1.94% Avg Daily Range (90 D): $0.53 | 1.64% Institutional Daily Volume Avg Daily Volume: .42M Avg Daily Volume (30 D): .73M Avg Daily Volume (90 D): .67M Trade Size Avg Trade Size (Sh.): 52 Avg Trade Size (Sh.) (30 D): 47 Avg Trade Size (Sh.) (90 D): 48 Institutional Trades Total Inst.Trades: 2,003 Avg Inst. Trade: $2.34M Avg Inst. Trade (30 D): $3.15M Avg Inst. Trade (90 D): $3M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.92M Avg Closing Trade (30 D): $4.29M Avg Closing Trade (90 D): $3.99M Avg Closing Volume: 81.38K     News Apr 8, 2025 @ 5:00 PM Developmental and Epileptic Encephalopathies Marke... Source: Delveinsight Jan 22, 2025 @ 6:00 PM 5-HT2 Agonist Clinical Trial Pipeline Appears Robu... Source: Delveinsight Dec 19, 2024 @ 6:00 PM Comprehensive Market Analysis of Latest Published ... Source: Delveinsight Oct 14, 2024 @ 2:46 PM Dravet Syndrome Drug Pipeline Research Report 2024... Source: Researchandmarkets.Com Aug 6, 2024 @ 12:45 PM Harmony Biosciences Holdings, Inc. (HRMY) Surpasse... Source: Zacks.Com Financials   TTM Q3 2025 Q2 2025 Basic EPS $3.23 $.88 $.69 Diluted EPS $3.18 $.87 $.68 Revenue $ 825.94M $ 239.46M $ 200.49M Gross Profit $ 641.74M $ 179.81M $ 162.34M Net Income / Loss $ 185.68M $ 50.87M $ 39.78M Operating Income / Loss $ 225.64M $ 65.49M $ 48.18M Cost of Revenue $ 184.21M $ 59.65M $ 38.15M Net Cash Flow $ 259.63M $ 100.95M $ 57.05M PE Ratio 12.33